Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q4 FY25 results · Jan–Mar 2025
Bajaj Healthcare reported revenue from operations of ₹154.47 crore (up 15.4% from Q4 FY24) and net profit of ₹11.18 crore for Q4 FY25 (Jan–Mar 2025), on a standalone basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 154.47 | 133.90 | +15.4% | 122.79 | +25.8% |
| Other income | 13.57 | 6.45 | +110.3% | 2.37 | +472.2% |
| Total income | 168.04 | 140.35 | +19.7% | 125.17 | +34.3% |
| Profit before tax | 11.72 | (35.15) | Turned profit | 11.65 | +0.6% |
| Net profit for the period | 11.18 | (29.92) | Turned profit | 11.72 | −4.6% |
| EPS, basic (₹) | 3.54 | (10.84) | not comparable | 3.65 | −3.0% |
| Net margin (%) | 7.2 | -22.3 | 9.5 |
Standalone
- Filed with BSE
- 26 May 2025, 20:20 IST
- Board meeting
- 26 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE